Comparative Molecular Docking and ADMET Analysis of Bioactive Compounds from Curcuma xanthorrhiza and Momordica charantia as Potential DPP-4 Inhibitors
Oshada · 28.02.2026 · 3 (1) · 162-173
DOI: 10.62872/o.v3i1.511 ↗Kurz gefasst
Fachartikel in der Zeitschrift Oshada, online erschienen am 28.02.2026. Verfasst von Nisrien Ilmia und 1 weiteren Autor:innen.
Abstract (Originalsprache)
Background
Type 2 Diabetes Mellitus (T2DM) is characterized by impaired insulin secretion and insulin resistance. Dipeptidyl Peptidase-4 (DPP-4) regulates glucose homeostasis by degrading incretin hormones such as GLP-1, making it a key therapeutic target. Natural bioactive compounds from Curcuma xanthorrhiza and Momordica charantia have demonstrated antidiabetic potential, but comparative evaluation of their activity as DPP-4 inhibitors remains limited.
Methods
Molecular docking was performed using CB-Dock2 integrated with AutoDock Vina against DPP-4 (PDB ID: 4A5S). Curcumin and xanthorrhizol from C. xanthorrhiza, and momordicin I and kuguacin J from M. charantia were evaluated. Sitagliptin was used as a positive control. Binding affinities and interactions with catalytic residues were analyzed. Pharmacokinetic and toxicity profiles were predicted using SwissADME and pkCSM.
Results
All compounds demonstrated favorable binding affinities (< –7.0 kcal/mol). Kuguacin J exhibited the strongest binding (–8.7 kcal/mol), slightly exceeding sitagliptin (–8.5 kcal/mol), followed by momordicin I (–8.3 kcal/mol), curcumin (–8.2 kcal/mol), and xanthorrhizol (–7.3 kcal/mol). Key interactions involved Glu205, Glu206, Ser630, Tyr547, and Tyr662, indicating active-site occupation. ADMET analysis showed compliance with Lipinski’s rule of five and high gastrointestinal absorption for all compounds. Kuguacin J demonstrated the most favorable safety profile with no predicted Ames toxicity or hepatotoxicity.
Conclusion
Kuguacin J emerges as the most promising natural DPP-4 inhibitor candidate based on combined docking and ADMET evaluation. Further experimental validation is required to confirm its therapeutic potential in T2DM management.
Zitieren
APA
Ilmia, N., & Fadhilah, N. A. (2026). Comparative Molecular Docking and ADMET Analysis of Bioactive Compounds from Curcuma xanthorrhiza and Momordica charantia as Potential DPP-4 Inhibitors. Oshada, 3(1), 162-173. https://doi.org/10.62872/o.v3i1.511
Vancouver
Ilmia N, Fadhilah NA. Comparative Molecular Docking and ADMET Analysis of Bioactive Compounds from Curcuma xanthorrhiza and Momordica charantia as Potential DPP-4 Inhibitors. Oshada. 2026;3(1):162-173. doi:10.62872/o.v3i1.511
BibTeX
@article{Ilmia2026,
author = {Ilmia, Nisrien and Fadhilah, Nur Aini},
title = {Comparative Molecular Docking and ADMET Analysis of Bioactive Compounds from Curcuma xanthorrhiza and Momordica charantia as Potential DPP-4 Inhibitors},
journal = {Oshada},
year = {2026},
volume = {3},
number = {1},
pages = {162--173},
doi = {10.62872/o.v3i1.511}
}
EUVIMED